Product Name: Orforglipron Intermediate
Synonyms: 5-[(S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl]-1-[(1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl]-1H-indole-2-carboxylic Acid
CAS: 2212021-83-3

This is a key pharmaceutical intermediate used in the synthesis of Orforglipron, a drug candidate for the treatment of type 2 diabetes and other metabolic disorders.

Product Details:
- High purity pharmaceutical intermediate
- Used in GLP-1 receptor agonist synthesis
- Suitable for pharmaceutical research and development
- Meets strict quality standards for API synthesis

Applications:
- Pharmaceutical intermediate for drug synthesis
- Research and development of GLP-1 receptor agonists
- Type 2 diabetes drug development
- Metabolic disorder treatments

Quality: High purity product manufactured under strict quality control standards suitable for pharmaceutical applications.

Packaging: Available in various package sizes to meet customer requirements.

Storage: Store in a cool, dry place away from light and heat sources. Keep container tightly closed when not in use.